These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1638529)

  • 1. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
    Kemp JD; Thorson JA; Stewart BC; Naumann PW
    Cancer Res; 1992 Aug; 52(15):4144-8. PubMed ID: 1638529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
    Kemp JD; Cardillo T; Stewart BC; Kehrberg E; Weiner G; Hedlund B; Naumann PW
    Cancer Res; 1995 Sep; 55(17):3817-24. PubMed ID: 7641199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
    Kemp JD; Smith KM; Kanner LJ; Gomez F; Thorson JA; Naumann PW
    Blood; 1990 Sep; 76(5):991-5. PubMed ID: 2393721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
    Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
    Hedley D; Rugg C; Musgrove E; Taylor I
    J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
    Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine.
    Thorson JA; Smith KM; Gomez F; Naumann PW; Kemp JD
    Cell Immunol; 1991 Apr; 134(1):126-37. PubMed ID: 1826464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
    Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
    Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.
    Amoroso AR; Clark JI; Litwin S; Hsieh-Ma S; Shi T; Alpaugh RK; Adams GP; Wolf EJ; Ring DB; Weiner LM
    Cancer Res; 1996 Jan; 56(1):113-20. PubMed ID: 8548750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic inhibition of T-lymphoblastic leukemic CCRF-CEM cell growth by gallium and recombinant human alpha-interferon through action on cellular iron uptake.
    Chitambar CR; Wereley JP; Riaz-ul-Haq
    Cancer Res; 1994 Jun; 54(12):3224-8. PubMed ID: 8205543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of transferrin receptors and their relationship to cell growth.
    Trowbridge IS; Shackelford DA
    Biochem Soc Symp; 1986; 51():117-29. PubMed ID: 3545211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R; Castagnola J; Mendelsohn J
    Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
    Moran PL; Seligman PA
    Cancer Res; 1989 Aug; 49(15):4237-41. PubMed ID: 2743310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
    Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
    Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
    Taetle R; Honeysett JM
    Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the transferrin receptor in lymphocyte growth: a rat IgG monoclonal antibody against the murine transferrin receptor produces highly selective inhibition of T and B cell activation protocols.
    Kemp JD; Thorson JA; McAlmont TH; Horowitz M; Cowdery JS; Ballas ZK
    J Immunol; 1987 Apr; 138(8):2422-6. PubMed ID: 2951439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells.
    Kemp JD; Smith KM; Mayer JM; Gomez F; Thorson JA; Naumann PW
    Pathobiology; 1992; 60(1):27-32. PubMed ID: 1543548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.